EM@3AM – Alcohol Withdrawal

Author: Eric Sulava, MD (EM Resident, USUHS, USN) and Erica Simon, DO, MHA (@E_M_Simon, EM Chief Resident, SAUSHEC, USAF) // Edited by: Alex Koyfman, MD (@EMHighAK, EM Attending Physician, UT Southwestern Medical Center / Parkland Memorial Hospital) and  Brit Long, MD (@long_brit, EM Attending Physician, SAUSHEC, USAF)

Welcome to EM@3AM, an emdocs series designed to foster your working knowledge by providing an expedited review of clinical basics. We’ll keep it short, while you keep that EM brain sharp.

A 36-year-old male presents to the emergency department after being found down at home by his spouse. Per the man’s wife, the patient is a heavy drinker – often consuming two to three pints of vodka daily. Upon EMS arrival the male is noted to be anxious and tremulous with a GCS of 14.

Initial vital signs: HR 136, BP 172/82, RR 24, T 37.2, SpO2 97% RA

What do you suspect as the diagnosis? What is the next step in evaluation and treatment?

Answer: Alcohol Withdrawal Syndrome (AWS)1-6

  • Pathophysiology: Alcohol => CNS depressant. It potentiates GABA receptors (enhances inhibitory tone) and antagonizes the NMDA receptors (inhibits excitatory tone).1 Withdrawal => CNS hyperexcitation and hyperstimulation.
  • Presentation: Four stages (clinically unreliable due to non-sequential progression and overlap of signs/symptoms):2,3
    • 6-12 Hours => Tremors, anxiety, gastrointestinal upset, anorexia, nausea, diaphoresis, palpitations, tachycardia, hypertension
    • 12-24 Hours => Alcoholic hallucinations (visual, auditory, or tactile in nature); occur in 3-5% of patients3
    • 24-48 Hours => Withdrawal seizures (generalized tonic-clonic)
    • 3-5 Days => Delirium Tremens
  • Evaluation: AWS is a diagnosis of exclusion. The use of a grading scale to assess symptoms is advised (Clinical Institute Withdrawal Assessment – Alcohol, revised (CIWA-Ar)).2-5
  • Treatment: Address ABCs. Benzodiazepines are first line (no single agent demonstrates superiority in treatment6):
  • Pearls:
    • Consider structural CNS pathology, metabolic abnormalities, infection, and toxicologic etiologies prior to assigning a diagnosis of AWS.
    • When interviewing the patient, question specifically regarding reasons for cessation of alcohol consumption =>may allow for identification of a concomitant condition (MI, pancreatitis, etc.)

 

References:

  1. Kosten T, O’Connor P. Management of drug and alcohol withdrawal. N Engl JMed. 2003; 348:1786-1795.
  2. Gortney J, Raub J, Patel P, et al. Alcohol withdrawal syndrome in medical patients. Cleve Clin J Med. 2016; 83(1): 67-79.
  3. Muncie H, Yasinian Y, Oge L. Outpatient management of alcohol withdrawal syndrome. Am Fam Physician. 2013; 88(9): 589-595.
  4. Perry E. Inpatient management of acute alcohol withdrawal syndrome. CNS Drugs. 2014; 28(5): 401-410.
  5. Sullivan J, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989; 84(11): 1353-1357.
  6. Yanta J, Swartzentruber G, Pizon A. Alcohol withdrawal syndrome: improving outcomes through early identification and aggressive treatment strategies. Emerg Med Pract. 2015; 17(6): 1-19.

 

For Additional Reading:

Alcohol Withdrawal: Pearls and Pitfalls:

Alcohol Withdrawal: Pearls and Pitfalls

Share This:

Leave a Comment

Your email address will not be published. Required fields are marked *

emDOCs subscribes to the Free Open Access Meducation (FOAMed) initiative. Our goal is to inform the global EM community with timely and high-yield content about what providers like YOU are seeing and doing daily in your local ED.

WRITE FOR EMDOCS

We are actively recruiting both new topics and authors.
This project is rolling and you can submit an idea or write-up anytime!
Contact us at editors@emdocs.net

news, headlines, newsletter

Join our Newsletter

Keep up to date on all of the latest new articles, studies, and Podcasts.
Men’s only search engine mr.